Article
PQA is described as a "a neutral convener of a multistakeholder base."
Laura Cranston, RpH, CEO of Pharmacy Quality Alliance discusses PQA's primary roles during the Pharmacy Quality Alliance (PQA) Annual Meeting in Baltimore, MD.
Transcript
Laura Cranston, RpH: PQA likes to think of itself not strictly as a measure developer but as a full-fledged quality organization, and as such, we engage in 4 primary activities: measure development and implementation is one, education around health care quality issue, research, and then the hallmark of PQA is that we are a neutral convener of a multistakeholder base. Often times when you are grappling with difficult quality issues the ability of PQA to convene a roundtable base of subject matter experts across stakeholders is really our key distinctive in the marketplace.
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.